Insulin aspart, recombinant Subcutaneous and Videx EC
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Videx EC and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Videx Pediatric
- Insulin aspart, recombinant Subcutaneous-Viekira
- Insulin aspart, recombinant Subcutaneous-Viekira Pak
- Insulin aspart, recombinant Subcutaneous-Viekira XR
- Insulin aspart, recombinant Subcutaneous-Vienva
- Insulin aspart, recombinant Subcutaneous-Vigabatrin
- Videx EC-Insulin degludec
- Videx EC-Insulin Degludec (U-100) Prefilled Pens
- Videx EC-Insulin Degludec (U-100) Vials
- Videx EC-Insulin Degludec (U-200) Prefilled Pens
- Videx EC-Insulin degludec and liraglutide
- Videx EC-Insulin degludec and liraglutide Subcutaneous